Modern Medicine Feature Articles

RF microneedling applicationsOne dermatologists describes her success with radiofreqency microneedling to treat acne and acne scarring.
Bone metastases Tx: 12-week dosing interval appears feasibleResults of a 2-year clinical trial support switching to a less frequent administration schedule when using zoledronic acid (Zometa) to prevent skeletal-related events in men with prostate cancer.
Studies reveal drop in PCa treatment, rise in metastatic diseaseFindings from two new studies provide insight on the impact of changing recommendations for prostate cancer screening and management.
Coding 2016 and beyondRecent Medicare changes include the apparent disappearance of consultation codes, the addition of site-specific soft-tissue excision codes, and increasing pressure from overseers and auditors, says an expert.
It’s about ocular health, not sales
It’s about ocular health, not salesContact lenses are medical devices. I can write it again and again. These are not commodities.
Keloid care and insurers – will they or won’t they pay?Insurers tend to think of keloids as a cosmetic issue so they have a wide range of standards covering reimbursement for care and treatments. Practitioners must fully document the medical necessity of the care they provide and then code the conditions and treatments correctly to maximize their chance for reimbursement.
HbA1c predicts diabetes risk in childrenThe easy-to-administer test was useful in predicting diabetes risk, and prediabetes status in children and adolescents.
Diabetes accounts for majority of U.S. healthcare spendingOf 155 conditions, personal healthcare spending on diabetes tops list, according to new study.
Diagnosing melanomaNewer tools to help diagnose challenging lesions include combined immunohistochemical stains and a growing array of genetic tests, one of which has shown the potential to gauge metastatic risk.
What cellulite? Cellfina leads the wayCellfina is subscision of the fibrous attachments between the skin and fat layers. It is the only FDA-cleared device to have solid three-year data showing that the cellulite doesn’t come back, expert says.